Experts now want to find out if the technology can help people with diabetes, of all ages, to effectively control their condition, in a real-world setting.

This article outlines the new NICE recommendations on the diagnosis of type 1 diabetes in adults, as well as the recommendations’ rationale and possible impact on clinical practice.

Quickly find out what the latest recommendations from NICE's three diabetes guidelines updates are and how they might impact on clinical practice.

This article outlines the new NICE recommendations on continuous glucose monitoring in adults with type 2 diabetes, as well as the recommendations’ rationale and possible impact on clinical practice.

This article outlines the new NICE recommendations on continuous glucose monitoring in children and young people with diabetes, as well as the recommendations’ rationale and possible impact on clinical practice.

This article outlines the new NICE recommendations on continuous glucose monitoring in adults with type 1 diabetes, as well as the recommendations’ rationale and possible impact on clinical practice.

Following the latest NICE advice, more than 250,000 people living with type 1 diabetes are set to be offered new technology to help them manage their condition. Use of flash monitoring is also extended to adults with type 2 diabetes on insulin therapy.

The authorisation holder for dapagliflozin has withdrawn the indication for type 1 diabetes mellitus. The removal of the type 1 diabetes indication is not due to any new safety concerns and the other indications of dapagliflozin are unchanged.